GC Cell Corporation (KOSDAQ:144510)
24,350
-1,050 (-4.13%)
At close: Feb 6, 2026
GC Cell Market Cap
GC Cell has a market cap or net worth of 365.91 billion as of February 6, 2026. Its market cap has decreased by -1.22% in one year.
Market Cap
365.91B
Enterprise Value
464.69B
Revenue
170.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
24,350.00
Market Cap Chart
Since June 23, 2016, GC Cell's market cap has decreased from 507.65B to 365.91B, a decrease of -27.92%. That is a compound annual growth rate of -3.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 365.91B | -2.01% |
| Dec 30, 2025 | 373.42B | 4.85% |
| Dec 30, 2024 | 356.14B | -47.90% |
| Dec 28, 2023 | 683.53B | -3.46% |
| Dec 29, 2022 | 708.04B | -55.94% |
| Dec 30, 2021 | 1.61T | 65.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HansBiomed | 601.52B |
| ToolGen | 508.74B |
| S.Biomedics | 400.04B |
| NIBEC | 368.79B |
| Y-Biologics | 359.72B |
| ABION | 327.97B |
| Genome & Company | 292.36B |
| curacle co.,ltd. | 260.93B |